T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor. T2 Biosystems, Inc. (NASDAQ:TTOO), a prominent name in the rapid detection of sepsis-causing pathogens and antibiotic-resistant genes, recently announced a major step in its commercial expansion strategy. The company has executed a territory-exclusive distribution agreement encompassing Malaysia and Indonesia. This strategic decision will see the...
T2 Biosystems股票讨论
T2 Biosystems的T2Candida体外诊断获得澳大利亚批准,该诊断用于从全血中检测引起败血症的真菌病原体
T2 Biosystems, Inc.(纳斯达克股票代码:TTOO)是快速检测诱发败血症的病原体和抗生素耐药基因方面的知名品牌,最近宣布了其商业扩张战略的重要一步。该公司已经签订了涵盖马来西亚和印度尼西亚的地区独家分销协议。这项战略决策将使...
T2 Biosystems, Inc. (NASDAQ:TTOO), a prominent name in the rapid detection of sepsis-causing pathogens and antibiotic-resistant genes, recently announced a major step in its commercial expansion strategy. The company has executed a territory-exclusive distribution agreement encompassing Malaysia and Indonesia. This strategic decision will see the...
t2 biosystems宣布通过马来西亚和印尼经销商进行商业扩张
t2 biosystems(纳斯达克:TTOO)宣布了一项独家领土分销协议,涵盖马来西亚和印尼,扩大了其国际商业存在。该协议允许t2 biosystems通过新任经销商销售其T2Dx®仪器和相关测试板。这一扩张跟随最近进入香港和澳门的行动,标志着在过去一个月内,已经覆盖了亚太地区四个新领土...
t2 biosystems:通过新任指定经销商销售 T2Dx 仪器、T2Bacteria 面板、T2Candida 面板、T2Resistance 面板
暂无评论